ELIZABETH E. TALLETT JOINS THE HEPREGEN BOARD OF DIRECTORS MEDFORD, Mass., Feb. 18, 2014 (GLOBE NEWSWIRE) -- Hepregen Corporation, leader in the development of next generation HepatoPacTM and HepatoMuneTM cell-based in vitro assay products, announced today...

HEPREGEN ANNOUNCES PUBLICATION OF SEVERAL SCIENTIFIC PAPERS PROVIDING EVIDENCE OF THE UNPRECEDENTED UTILITY OF ITS HEPATOPACTM PRODUCTS MEDFORD, Mass., Feb. 12, 2014 (GLOBE NEWSWIRE) -- Hepregen Corporation, leader in the development of next generation HepatoPacTM and HepatoMuneTM cell-based in vitro assay products, announced today...

HEPREGEN LAUNCHES FIRST MONKEY HEPATOPACTM ASSAY KITS AT ANNUAL USER GROUP MEETING CAMBRIDGE, MASS., Oct. 29, 2013 (GLOBE NEWSWIRE) -- Today, at the Company's annual User Group Meeting, Hepregen Corporation, leader in the development of next generation HepatoPacTM and...

HEPREGEN LAUNCHES MULTI-DONOR HUMAN HEPATOPACTM ASSAY KITS AT 10th ANNUAL ISSX MEETING TORONTO, ON, Sept. 30, 2013 (GLOBE NEWSWIRE) -- Today, at the annual meeting of the International Society for the Study of Xenobiotics ("ISSX"), Hepregen Corporation, leader in the development of next...